Mabel Wong

918 total citations
24 papers, 517 citations indexed

About

Mabel Wong is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Mabel Wong has authored 24 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Mabel Wong's work include Breast Cancer Treatment Studies (5 papers), Neutropenia and Cancer Infections (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Mabel Wong is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Neutropenia and Cancer Infections (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Mabel Wong collaborates with scholars based in Singapore, United Kingdom and Canada. Mabel Wong's co-authors include Yoon Sim Yap, Raymond Ng, Alexandre Chan, Denise L. Spitzer, A Wilkinson, Nan Soon Wong, Joanne Lim, Onkar Singh, Edmund J.D. Lee and Balram Chowbay and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Mabel Wong

21 papers receiving 499 citations

Peers

Mabel Wong

PRM

ONCOL

GENET

Frank S Ong United States

Henning Wittenburg Germany

So Won Kim South Korea

Hengyue Zhu China

U Peters Germany

Lei‐Yun Wang China

M. Winkelmann Germany

Chen‐Xue Mao China

Wei Zou China

Frank S Ong United States

Mabel Wong

108 ×0.6

PRM

74 ×0.5

ONCOL

56 ×0.6

GENET

72 ×0.8

GENET

274 ×3.0

Citations per year, relative to Mabel Wong Mabel Wong (= 1×) peers Frank S Ong

Countries citing papers authored by Mabel Wong

Since Specialization

Citations

This map shows the geographic impact of Mabel Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mabel Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mabel Wong more than expected).

Fields of papers citing papers by Mabel Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mabel Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mabel Wong. The network helps show where Mabel Wong may publish in the future.

Co-authorship network of co-authors of Mabel Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Mabel Wong. A scholar is included among the top collaborators of Mabel Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mabel Wong. Mabel Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shih, Vivianne, Jack Junjie Chan, Stella Liong, et al.. (2025). Evaluating the impact of relative dose intensity on efficacy of trastuzumab deruxtecan for metastatic breast cancer in the real-world clinical setting. Annals of the Academy of Medicine Singapore. 54(8). 458–458.

Tan, Si Ying, Mabel Wong, Jingmei Li, et al.. (2024). Combined aerobic and strength exercise training on biological ageing in Singaporean breast cancer patients: protocol for the Breast Cancer Exercise Intervention (BREXINT) Pilot Study. GeroScience. 46(6). 6029–6038. 1 indexed citations

Zhou, Siqin, et al.. (2024). Can metastatic breast cancer be cured? Long-term follow up of patients diagnosed from 2001–2012. European Journal of Cancer. 200. 113713–113713.

Chong, Jun Hua, Wei‐Ting Chang, Jack Junjie Chan, et al.. (2024). The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction – A systematic review. Current Problems in Cardiology. 49(3). 102372–102372. 4 indexed citations

Saw, Stephanie P.L., et al.. (2019). Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice. Breast Cancer Research and Treatment. 177(1). 197–206. 10 indexed citations

Fishman, Mayer, Janice P. Dutcher, Neeraj Agarwal, et al.. (2019). Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM. 7(1). 84. 5 indexed citations

George, Angela, Rebecca Kristeleit, Saeed Rafii, et al.. (2017). Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials. European Journal of Cancer. 76. 52–59. 8 indexed citations

Miao, Hui, Joline S.J. Lim, Soo Chin Lee, et al.. (2016). Outcome after neoadjuvant chemotherapy in Asian breast cancer patients. Cancer Medicine. 6(1). 173–185. 11 indexed citations

Khan, Khurum, Mabel Wong, Karim Rihawi, et al.. (2016). Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management. The Oncologist. 21(7). 855–860. 49 indexed citations

10.

Cheung, Yin Ting, Terence Ng, Han Kiat Ho, et al.. (2015). Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Annals of Oncology. 26(7). 1446–1451. 186 indexed citations

11.

Ng, Terence, Shu Mei Teo, Hui Ling Yeo, et al.. (2015). Evaluation of brain-derived neurotrophic factor (BDNF) genetic polymorphism (rs6265) on chemotherapy-associated cognitive impairment in early-stage breast cancer (ESBC) patients.. Journal of Clinical Oncology. 33(15_suppl). 9616–9616. 4 indexed citations

12.

Chung, I‐Fang, István Láng, Tibor Csőszi, et al.. (2015). 2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population pharmacokinetics (PK) and its association with efficacy and safety in patients with solid tumors based on the phase 3 study NAPOLI-1 and five phase 1 and 2 studies. European Journal of Cancer. 51. S458–S458. 1 indexed citations

13.

Wang, X‐J, Mabel Wong, Li Yang Hsu, & Alexandre Chan. (2014). Economic Burden of Febrile Neutropenia in Solid Tumor and Lymphoma Patients: An Observational Study in Singapore. Value in Health. 17(7). A734–A734. 3 indexed citations

14.

Wang, Xiao Jun, Mabel Wong, Li Yang Hsu, & Alexandre Chan. (2014). Costs associated with febrile neutropenia in solid tumor and lymphoma patients – an observational study in Singapore. BMC Health Services Research. 14(1). 434–434. 13 indexed citations

15.

Chan, Alexandre, et al.. (2013). Clinical efficacy of adjunctive G-CSF on solid tumor and lymphoma patients with established febrile neutropenia. Supportive Care in Cancer. 22(4). 1105–1112. 9 indexed citations

16.

Khan, Khurum, Anna-Mary Young, Joaquı́n Mateo, et al.. (2013). Phase I clinical trial of a genetically modified and oncolytic vaccinia virus GL-ONC1 with green fluorescent protein imaging (NCT009794131).. Journal of Clinical Oncology. 31(15_suppl). 3062–3062. 5 indexed citations

17.

Lim, Joanne, et al.. (2012). Genetic Variations of NR1I3 and NR2B1 in Asian Populations. Drug Metabolism and Pharmacokinetics. 28(2). 169–176. 2 indexed citations

18.

Lim, Joanne, Onkar Singh, Yoon Sim Yap, et al.. (2011). Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. British Journal of Clinical Pharmacology. 71(5). 737–750. 100 indexed citations

19.

Wong, Mabel, et al.. (1982). CHLOROQUINE AS A PROBE FOR ANTIGEN PROCESSING BY ACCESSORY CELLS1. Transplantation. 34(3). 150–152. 45 indexed citations

20.

Wilkinson, A, et al.. (1979). Antigen-specific murine T-cell proliferation: Role of macrophage surface Ia and factors. Cellular Immunology. 48(1). 79–90. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact